NO941444L - Fremgangsmåte og materiale for bestemmelse av bioaktive substansers immunologiske aktivitet - Google Patents

Fremgangsmåte og materiale for bestemmelse av bioaktive substansers immunologiske aktivitet

Info

Publication number
NO941444L
NO941444L NO941444A NO941444A NO941444L NO 941444 L NO941444 L NO 941444L NO 941444 A NO941444 A NO 941444A NO 941444 A NO941444 A NO 941444A NO 941444 L NO941444 L NO 941444L
Authority
NO
Norway
Prior art keywords
determining
bioactive substances
immunological activity
tested
determined
Prior art date
Application number
NO941444A
Other languages
English (en)
Norwegian (no)
Other versions
NO941444D0 (no
Inventor
Anna Inglot
Zofia Blach-Olszewska
Original Assignee
Torf Ets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torf Ets filed Critical Torf Ets
Publication of NO941444D0 publication Critical patent/NO941444D0/no
Publication of NO941444L publication Critical patent/NO941444L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO941444A 1991-10-26 1994-04-21 Fremgangsmåte og materiale for bestemmelse av bioaktive substansers immunologiske aktivitet NO941444L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91118269A EP0539610A1 (en) 1991-10-26 1991-10-26 Method and composition for determining the immunological activity of solutions containing active substances
PCT/EP1992/002228 WO1993008470A1 (en) 1991-10-26 1992-09-28 Method and composition for determining the immunological activity of bioactive substances

Publications (2)

Publication Number Publication Date
NO941444D0 NO941444D0 (no) 1994-04-21
NO941444L true NO941444L (no) 1994-06-16

Family

ID=8207282

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941444A NO941444L (no) 1991-10-26 1994-04-21 Fremgangsmåte og materiale for bestemmelse av bioaktive substansers immunologiske aktivitet

Country Status (22)

Country Link
US (1) US5543300A (enEXAMPLES)
EP (2) EP0539610A1 (enEXAMPLES)
JP (1) JPH07500905A (enEXAMPLES)
AT (1) ATE153763T1 (enEXAMPLES)
AU (1) AU678343B2 (enEXAMPLES)
BG (1) BG61705B1 (enEXAMPLES)
CA (1) CA2122131A1 (enEXAMPLES)
CZ (1) CZ100494A3 (enEXAMPLES)
DE (3) DE539610T1 (enEXAMPLES)
DK (1) DK0609255T3 (enEXAMPLES)
ES (1) ES2061424T3 (enEXAMPLES)
FI (1) FI941920L (enEXAMPLES)
GR (3) GR930300100T1 (enEXAMPLES)
HU (1) HU216863B (enEXAMPLES)
LV (1) LV12140B (enEXAMPLES)
NO (1) NO941444L (enEXAMPLES)
PL (1) PL170592B1 (enEXAMPLES)
RO (1) RO114837B1 (enEXAMPLES)
RU (1) RU2125727C1 (enEXAMPLES)
SG (1) SG72665A1 (enEXAMPLES)
SK (1) SK44094A3 (enEXAMPLES)
WO (1) WO1993008470A1 (enEXAMPLES)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615470A1 (de) * 1996-04-19 1997-10-23 Heinz Beinio Körperpflegemittel und Verfahren zu seiner Herstellung
WO2000016786A2 (en) * 1998-09-23 2000-03-30 Enerkom (Proprietary) Limited Oxihumic acid and its use in the treatment of various conditions
RU2180120C1 (ru) * 2000-07-05 2002-02-27 Научно-исследовательский институт детских инфекций Способ выявления цитокинов
GB0101973D0 (en) * 2001-01-25 2001-03-14 Statens Seruminstitut Improved in vitro diagnostic method of detecting a cell-mediated immune response
RU2226275C2 (ru) * 2002-04-15 2004-03-27 Научно-исследовательский и учебно-методический центр биомедицинских технологий ВИЛАР Способ определения цитотоксического эффекта и ростстимулирующей активности веществ для доклинических испытаний
EP1449535B1 (en) * 2003-02-18 2006-05-03 Clinique La Prairie Research SA Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components
US7497947B2 (en) 2004-04-14 2009-03-03 Embro Corporation Devices for water treatment
US7614340B2 (en) * 2007-02-09 2009-11-10 Honeywell International Inc. Composite piston housing for aircraft brakes
EP2753422A1 (en) 2011-09-07 2014-07-16 Embro Corporation Use of moss to reduce disinfection by-products in water treated with disinfectants
US9795809B2 (en) 2013-12-23 2017-10-24 Embro Corporation Use of moss to improve dental health
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH636448A5 (en) * 1977-05-06 1983-05-31 Horst Veith Process for the determination of the effect of substances on constituents of the blood for the detection of infectious and immunological processes and composition for carrying it out
NZ214400A (en) * 1985-12-02 1989-05-29 Univ Otago Detecting infection in ruminant including conducting assay of mononuclear cell function
EP0238851B1 (en) * 1986-02-19 1992-12-09 Imreg, Inc. A method and means of assaying an immune system
CA1299099C (en) * 1986-03-06 1992-04-21 Paul Richard Wood In vitro assay for detecting cell-mediated immune responses
US5096708A (en) * 1988-07-07 1992-03-17 Sven Gohla Medical preparation containing as active agent a component from thuja plants which comprises polysaccharides
AU1360492A (en) * 1991-03-16 1992-10-21 Torf Establishment Process for the extraction of peat and apparatus for carrying out the process

Also Published As

Publication number Publication date
DK0609255T3 (da) 1997-12-22
DE609255T1 (de) 1995-06-14
AU678343B2 (en) 1997-05-29
DE69220078T2 (de) 1997-12-04
US5543300A (en) 1996-08-06
NO941444D0 (no) 1994-04-21
DE539610T1 (de) 1993-12-16
HK1002610A1 (en) 1998-09-04
WO1993008470A1 (en) 1993-04-29
GR3024457T3 (en) 1997-11-28
ATE153763T1 (de) 1997-06-15
EP0609255A1 (en) 1994-08-10
PL170592B1 (en) 1997-01-31
SK44094A3 (en) 1995-03-08
GR940300077T1 (en) 1994-11-30
FI941920A7 (fi) 1994-04-25
GR930300100T1 (enEXAMPLES) 1993-10-29
FI941920A0 (fi) 1994-04-25
LV12140B (lv) 1998-12-20
HU9401185D0 (en) 1994-07-28
AU2650992A (en) 1993-05-21
ES2061424T1 (es) 1994-12-16
HU216863B (hu) 1999-09-28
CZ100494A3 (en) 1994-11-16
BG61705B1 (bg) 1998-03-31
SG72665A1 (en) 2000-05-23
CA2122131A1 (en) 1993-04-29
DE69220078D1 (de) 1997-07-03
RU94022481A (ru) 1996-09-27
JPH07500905A (ja) 1995-01-26
ES2061424T3 (es) 1997-10-01
RU2125727C1 (ru) 1999-01-27
EP0539610A1 (en) 1993-05-05
FI941920L (fi) 1994-04-25
RO114837B1 (ro) 1999-07-30
LV12140A (lv) 1998-09-20
HUT69990A (en) 1995-09-28
EP0609255B1 (en) 1997-05-28
BG98720A (bg) 1995-07-28

Similar Documents

Publication Publication Date Title
ATE65505T1 (de) Biologisch aktive fragmente von humanem antihaemophiliefaktor, methode zu ihrer herstellung und pharmazeutische praeparate.
NO941444L (no) Fremgangsmåte og materiale for bestemmelse av bioaktive substansers immunologiske aktivitet
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
ATE295176T1 (de) Verfahren zur unterstützung der differentialdiagnostik und behandlung von autistischen syndromen
RU98100114A (ru) Использование нейро-производных эмбриональных клеточных линий для трансплантационной терапии
DE68906735D1 (de) Pharmazeutische zubereitung zur behandlung von viruskrankheiten mit leber-extrakt.
ATE69953T1 (de) Verwendung von polysulfatierten heparinen.
BE858521A (fr) Proteine specifique de tissus organiques et leur procede de preparation
US4273871A (en) Production of angiogenic factor by cell culture
NO893135D0 (no) Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater.
ES8604990A1 (es) Procedimiento para la inactivacion de sustancias que provocan reacciones de incompatibilidad en productos sanguineos
NO173336C (no) Fremgangsm}te til isolering av basalmembranproteiner fra human- eller animalvev og anvendelse av det oppn}dde protein
Bomalaski et al. Rheumatoid arthritis synovial fluid phospholipase A2 activating protein (PLAP) stimulates human neutrophil degranulation and superoxide ion production
DK0538330T3 (da) Beta-Alethin-anvendelse til celledyrkning og terapi
DE3855761D1 (de) Verfahren und Materialien zum Nachweis und Therapie von HIV
Müller Influence of ionizing radiation on the appearance in the serum of rabbits of humoral factors slowing down cell division
UA13475A (uk) СПОСІБ ОДЕРЖАННЯ 6-БЕНЗИЛОКСИЗАМІЩЕНИХ ІЗОПРОПІЛОВИХ ЕФІРІВ beta-КАРБОЛІН-3-КАРБОНОВОЇ КИСЛОТИ
SU1613956A1 (ru) Средство дл модул ции функциональной активности естественных киллеров IN VIтRо
Brady et al. Elaboration of steroid hormones by surviving adrenal tissue slices obtained from thermally stressed dogs.
JPS5726625A (en) Sustained release type composite material entrapping medical enzyme and its preparation
Sandberg et al. Stimulation of prostaglandin synthesis with resultant bone resorption by the classical and alternative C pathways
Giron et al. Enhancement of encephalomyocarditis virus replication in L cells treated with insulin
Inglot et al. Method and composition for determining the immunological activity of bioactive substances
Rudofsky et al. Synthesis of C4 by C4 deficient NIH-Albany strain guinea pig radiation chimeras: Restoration of the classical pathway of complement
DE58901297D1 (de) Noremopamil, seine herstellung und verwendung.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application